ConductScience.org, home

Paper7831367

Initial studies on the administration of C1-esterase inhibitor to patients with septic shock or with a vascular leak syndrome induced by interleukin-2 therapy.

Hack CE and 5 others. Prog Clin Biol Res, 1994. Cited by 30 papers, by iCite.

Cite this record

ConductScience Library. Initial studies on the administration of C1-esterase inhibitor to patients with septic shock or with a vascular leak syndrome induced by interleukin-2 therapy. Papers, record 7831367. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/7831367

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Initial studies on the administration of C1-esterase inhibitor to patients with septic shock or with a vascular leak syndrome induced by interleukin-2 therapy.
PubMed
Journal
Prog Clin Biol Res
PubMed
Year
1994
PubMed
Publication types
Journal Article, Review
PubMed
Citations, by iCite
30
iCite
Relative citation ratio, by iCite
1.03
iCite
Revised in PubMed
2005-11-17
PubMed

Authors6

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Hack CEC E
2Ogilvie ACA C
3Eisele BB
4Jansen PMP M
5Wagstaff JJ
6Thijs LGL G

Source PubMed

Download CSV of authors

Topics9

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Capillary PermeabilityMajor topic
Complement C1 Inactivator ProteinsMajor topic
Interleukin-2Major topic
Shock, SepticMajor topic
Blood Coagulation
Complement Activation
Humans
Structure-Activity Relationship
Syndrome

Source PubMed

Download CSV of topics

Cited by12

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 30 citations.

PMIDTitleJournalYearIn PapersSource
41410053Therapeutic Potential of C1-Inhibitor in Vascular Diseases and Beyond.Arterioscler Thromb Vasc Biol2026https://conductscience.org/library/papers/41410053PubMed
25034232Complement blockade with a C1 esterase inhibitor in paroxysmal nocturnal hemoglobinuria.Exp Hematol2014https://conductscience.org/library/papers/25034232PubMed
24884532Intravenous ascorbic acid as an adjuvant to interleukin-2 immunotherapy.J Transl Med2014https://conductscience.org/library/papers/24884532PubMed
23351964Positive effect of septimeb™ on mortality rate in severe sepsis: a novel non antibiotic strategy.Daru2012https://conductscience.org/library/papers/23351964PubMed
22792226Rapid vascular responses to anthrax lethal toxin in mice containing a segment of chromosome 11 from the CAST/Ei strain on a C57BL/6 genetic background.PLoS One2012https://conductscience.org/library/papers/22792226PubMed
21345278Bench-to-bedside review: the role of C1-esterase inhibitor in sepsis and other critical illnesses.Crit Care2011https://conductscience.org/library/papers/21345278PubMed
17544816C1 inhibitor: biologic activities that are independent of protease inhibition.Immunobiology2007https://conductscience.org/library/papers/17544816PubMed
16367929Inhibition of classical complement activation attenuates liver ischaemia and reperfusion injury in a rat model.Clin Exp Immunol2006https://conductscience.org/library/papers/16367929PubMed
16267649C1 inhibitor: molecular and clinical aspects.Springer Semin Immunopathol2005https://conductscience.org/library/papers/16267649PubMed
14586496Effects of C1 esterase inhibitor administration on intestinal functional capillary density, leukocyte adherence and mesenteric plasma extravasation during experimental endotoxemia.Intensive Care Med2004https://conductscience.org/library/papers/14586496PubMed
9784543Complement activation in relation to capillary leakage in children with septic shock and purpura.Infect Immun1998https://conductscience.org/library/papers/9784543PubMed
8887038Effects of high-dose intraperitoneal aprotinin treatment on complement activation and acute phase response in acute severe pancreatitis.J Gastroenterol1996https://conductscience.org/library/papers/8887038PubMed

Download CSV of cited by

Genes2

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
IL23558PubTator's text mininghttps://conductscience.org/library/genes/3558NCBI Gene
SERPING1710PubTator's text mininghttps://conductscience.org/library/genes/710NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/7831367

GET https://conductscience.org/api/papers/v1/7831367/authors